x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The Readout Loud

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

business

All Episodes

25:07

Episode 102: Voices from the coronavirus pandemic, in...

The Readout Loud ·

2020/03/12

How long will this pandemic persist? Are U.S. hospitals going to be overwhelmed? And what’s it like to be quarantined on a cruise ship?

en

28:29

Episode 101: Pharma’s response to coronavirus,...

The Readout Loud ·

2020/03/05

Does “The Art of the Deal” cover vaccines? Is patient privacy a relic of the past? And how big can biotech get in China?

en

28:47

Episode 100: Wall Street's coronavirus freakout,...

The Readout Loud ·

2020/02/27

Is the market overreacting to the coronavirus? Why do so many clinical trials go unfilled? And how do you pronounce "Martin Shkreli"?

en

29:56

Episode 99: Genetic medicine w/ Ethan Weiss, drug...

The Readout Loud ·

2020/02/20

Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug?

en

24:49

Episode 98: Les Funtleyder on biotech investing; the...

The Readout Loud ·

2020/02/13

What's the right way to give drugs away? Is $3 billion even a lot of money? And when is biotech hype justified?

en

23:30

Episode 97: Fake outbreak news, treating coronavirus,...

The Readout Loud ·

2020/02/06

Is peer review underrated? Can biotech stop an outbreak? And would you mind giving us a call? We're coming up on the 100th episode of this podcast, and we're using the occasion to actualize our long-held dream of running a call-in show. Dial us at 617-517-6130 and leave a message with any question you'd like us to answer on the podcast, and you may just hear it on air in the coming weeks.

en

26:19

Episode 96: A chemist breaks bad, the latest on the...

The Readout Loud ·

2020/01/30

Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously? And what constitutes a "public health emergency of international concern?"

en

22:02

Episode 95: The latest on the China virus, Sarepta's...

The Readout Loud ·

2020/01/23

Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about?

en

23:15

Episode 94: EQRx's Alexis Borisy, Stephen Buck on his...

The Readout Loud ·

2020/01/16

Why weren't there any big deals announced this week? What does the word "equivalar" mean? And why is information about prognosis so hard to find?

en

26:29

Episode 93: Josiah Zayner on getting canceled, good...

The Readout Loud ·

2020/01/09

Does pharma deserve more credit? Will history forgive He Jiankui? And how does a laboratory eureka become a lifesaving vaccine?

en

24:51

Episode 92: The decade in breakthroughs, the year in...

The Readout Loud ·

2019/12/19

Which drug defined the decade? Who's the worst CEO in biopharma? And how does gene therapy actually work?

en

25:29

Episode 91: CAR-T's future, an alarming cancer trend...

The Readout Loud ·

2019/12/12

Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016?

en

24:46

Episode 90: Biogen's big reveal, hot takes on...

The Readout Loud ·

2019/12/05

How do you know if a "positive" study is positive? And how did one-eyed sheep lead to a drug for certain cancers?

en

24:56

Episode 89: Warren's awkward home front, a dwarfism...

The Readout Loud ·

2019/11/22

Can Sen. Elizabeth Warren ever go home again? Is it ethical to make little people taller? And when will AI come up with a new drug?

en

25:58

Episode 88: Dr. David Sable on an alarming genetic...

The Readout Loud ·

2019/11/14

Do you trust Google with your health data? Is "Gattaca" an outdated reference? And what's it like to get dunked on?

en

20:06

Episode 87: Derek Lowe on China's new Alzheimer's...

The Readout Loud ·

2019/11/07

Why hope for China's new Alzheimer's drug turned into skepticism ? Is three a crowd in CAR-T? And what's a Bionomy?

en

28:13

Episode 86: Drugs that don't work, wearables in the...

The Readout Loud ·

2019/10/31

When should a drug be pulled from shelves? How do you pronounce "HLTH?" And how does Ann Coulter decide what to tweet?

en

28:18

Episode 85: Every angle on Biogen's shocking...

The Readout Loud ·

2019/10/24

What exactly is Biogen doing? When is a press release worth $12 billion? And what should patients make of whiplashing news? We're devoting this entire episode to Biogen's stunning announcement that aducanumab, its once-discarded treatment for Alzheimer's disease, is getting a second life.

en

26:13

Episode 84: CRISPR with Netflix filmmakers, Pharma's...

The Readout Loud ·

2019/10/17

Should drug companies be free-speech advocates? Is your retirement dependent on CRISPR? And how useful is a glow-in-the-dark dog?

en

23:46

Episode 83: How biotech VC works w/ health care...

The Readout Loud ·

2019/10/10

STAT's Matthew Herper joins us to dig into the history of the infamous pain drug Vioxx and a new effort to bring it back as a rare disease treatment. Then, we discuss how the synthetic biology industry is growing up and getting corporate. Finally, health care journalist Maggie Fox dials in to explain her deep dive on venture capital in biotech.

en

383 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...